Accès gratuit
Numéro
Med Sci (Paris)
Volume 24, Numéro 5, Mai 2008
Page(s) 525 - 528
Section M/S revues
DOI https://doi.org/10.1051/medsci/2008245525
Publié en ligne 15 mai 2008
  1. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155 : 1151–64. [Google Scholar]
  2. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299 : 1057–61. [Google Scholar]
  3. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4 : 330–6. [Google Scholar]
  4. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198 : 1875–86. [Google Scholar]
  5. Allan SE, Crome SQ, Crellin NK, et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19 : 345–54. [Google Scholar]
  6. Ueno H, Klechevsky E, Morita R, et al. Dendritic cell subsets in health and disease. Immunol Rev 2007; 219 : 118–42. [Google Scholar]
  7. Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005; 5 : 296–306. [Google Scholar]
  8. Dudziak D, Kamphorst AO, Heidkamp GF, et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007; 315 : 107–11. [Google Scholar]
  9. Fitzgerald-Bocarsly P, Dai J, Singh S. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev 2008; 19 : 3–19. [Google Scholar]
  10. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957; 147 : 258–67. [Google Scholar]
  11. Isaacs A, Lindenmann J, Valentine RC. Virus interference. II. Some properties of interferon. Proc R Soc Lond B Biol Sci 1957; 147 : 268–73. [Google Scholar]
  12. Ferbas JJ, Toso JF, Logar AJ, et al. CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. J Immunol 1994; 152 : 4649–62. [Google Scholar]
  13. Sapoznikov A, Fischer JA, Zaft T, et al. Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells. J Exp Med 2007; 204 : 1923–33. [Google Scholar]
  14. Taieb J, Chaput N, Menard C, et al. A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med 2006; 12 : 214–9. [Google Scholar]
  15. Chan CW, Crafton E, Fan HN, et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med 2006; 12 : 207–13. [Google Scholar]
  16. Bonmort M, Dalod M, Mignot G, et al. Killer dendritic cells: IKDC and the others. Curr Opin Immunol 2008 (sous presse). [Google Scholar]
  17. Blasius AL, Barchet W, Cella M, Colonna M. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells. J Exp Med 2007; 204 : 2561–8. [Google Scholar]
  18. Caminschi I, Ahmet F, Heger K, et al. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J Exp Med 2007; 204 : 2579–90. [Google Scholar]
  19. Vosshenrich CA, Lesjean-Pottier S, Hasan M, et al. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J Exp Med 2007; 204 : 2569–78. [Google Scholar]
  20. Spits H, Lanier LL. Natural killer or dendritic: what’s in a name ? Immunity 2007; 26 : 11–6. [Google Scholar]
  21. Ullrich E, Bonmort M, Mignot G, et al. Trans-presentation of interleukin-15 dictates IKDC effector functions. 2008 (sous presse). [Google Scholar]
  22. Welner RS, Pelayo R, Garrett KP, et al. Interferon-producing killer dendritic cells (IKDCs) arise via a unique differentiation pathway from primitive c-kitHiCD62L+ lymphoid progenitors. Blood 2007; 109 : 4825–31. [Google Scholar]
  23. Mignot G, Ullrich E, Bonmort M, et al. The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2. J Immunol 2008 (sous presse). [Google Scholar]
  24. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006; 176 : 1517–24. [Google Scholar]
  25. Ullrich E. Boston : Federation of Clinical Immunology Societies (FOCIS), 2008. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.